Cure My Disease

Don't miss your cure!

 Log in / Sign up

New bladder cancer drug TARA-002 faces chemotherapy in major trial

NCT ID NCT07480356

Recruiting now Disease control Sponsor: Protara Therapeutics Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times

Summary

This phase 3 trial tests whether a new drug, TARA-002, works better than standard chemotherapy for a type of early-stage bladder cancer. About 284 adults who have not received BCG therapy will be randomly assigned to receive either TARA-002 or chemotherapy directly into the bladder. The study will check if the cancer disappears and how long that lasts, while also monitoring side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bladder carcinoma in situ in situ carcinoma neoplasm non-invasive bladder urothelial carcinoma Non-Muscle Invasive Bladder Neoplasms urinary bladder carcinoma Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER NON-MUSCLE INVASIVE BLADDER CANCER WITH CARCINOMA IN SITU NON-MUSCLE INVASIVE BLADDER CARCINOMA

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Arensia Kapitanivka - PPDS

    RECRUITING

    Kapitanivka, 08111, Ukraine

  • Arkansas Urology

    RECRUITING

    Little Rock, Arkansas, 72211, United States

  • East Valley Urology Center of Arizona

    RECRUITING

    Queen Creek, Arizona, 85140, United States

  • Michael Oefelein Clinical Trials

    RECRUITING

    Bakersfield, California, 93301, United States

  • Renown Regional Medical Center

    RECRUITING

    St Louis, Missouri, 63110, United States

  • START - Carolinas

    RECRUITING

    Myrtle Beach, South Carolina, 29572, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.